A randomized controlled trial hysterectomy of levenorgestrel-releasing intrauterine system in the treatment of menorrhagia - Effect of FSH levels and menopausal symptoms

Human Reproduction

Volumn 19, Issue 2, 2004, Pages 378-382

  Halmesmaki K ^a   Hurskainen, R ^b   Tiitinen, A ^b   Teperi, J ^c   Grenman, S ^d   Kivela A ^e   Kujansuu, E ^f   Yliskoski, M ^g   Paavonen, J ^b  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Health Services Research Unit   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

FSH; Hot flushes; Hyterectomy; Levonorgestrel releasing intrauterine system; Menopausal symptoms

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN; LEVONORGESTREL;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; HYSTERECTOMY; INSOMNIA; INTERMETHOD COMPARISON; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MELANCHOLIA; MENOPAUSAL SYNDROME; MENORRHAGIA; MUSCLE WEAKNESS; MYALGIA; NEUROLOGIC DISEASE; NIGHT SWEAT; OVARY INSUFFICIENCY; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TIME; UNIVERSITY HOSPITAL; VERTIGO;

EID: 1242341400     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh055     Document Type: Article

References (34)

1. Barbosa I, Bakos O, Olsson SE, Odlind V and Johansson ED (1990) Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 42,51-66.
2. Beavis ELG, Brown JB and Smith MA (1969) Ovarian function after hysterectomy with conservation of the ovaries in pre-menopausal women. J Obstet Gynecol Br Cwlth 76,969-978.
3. Buekers T, Anderson B, Sorosky, JI and Buller RE (2001) Ovarian function after surgical treatment for cervical cancer. Gynecol Oncol 80,85-88.
4. Burger H, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A and Dennerstein L (1999) Prospectively measured levels of follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84,4025-4030.
5. Cooper GS and Thorp JM (1999) FSH levels in relation to hysterectomy and to unilateral oophorectomy. Obstet Gynecol 94,969-972.
6. Coppen A, Bishop M, Beard RJ, Barnard GJR and Collins WP (1981) Hysterectomy, hormones and behaviour - a prospective study. Lancet 1,126-128.
7. Coulter A, McPherson K and Vessey M (1988) Do British women undergo too many or too few hysterectomies? Soc Sci Med 27,987-994.
8. DeNeef JC and Hollenbeck ZJR (1966) The fate of ovaries at the time of hysterectomy. Am J Obstet Gynecol 96,1088-1097.
9. Derksen JG, Brolmann HA, Wiegerinck MA, Vader HL and Heintz AP (1998) The effect of hysterectomy and endometrial ablation on follicle stimulating hormone (FSH) levels up to 1 year after surgery. Maturitas 29,133-138.
10. Dogan M.M, Basaran Z, Ekici E, Basaran O, Ozcan T, Gokay Z. and Gokmen O. (1998) Effect of hysterectomy on ovarian blood supply and function. J Obstet Gynecol 18,263-267.
11. Ellsworth LR, Allen HH and Nisker JA (1983) Ovarian function after radical hysterectomy for stage IB carcinoma of cervix. Am J Obstet Gynecol 145,185-188.
12. Erdem A, Erdem M, Biberoglu K, Hayit O, Arsla M and Gursoy R (2002) Age-related changes in ovarian volume, antral follicle counts and basal FSH levels in women with normal reproductive health. J Reprod Med 47,835-839.
13. Feeney DD, Moore DH, Look KY, Stehman FB and Sutton GP (1995) The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol 56,1-2.
14. Hartmann BW, Kirchergast S, Albrecht A, Metka M and Huber JC (1995) Hysterectomy increases the symptomatology of postmenopausal syndrome. Gynecol Endocrinol 9,247-252.
15. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M and Paavonen J (2001) Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia; a randomised controlled trial. Lancet 357,273-277.
16. Kaiser R, Kusche M and Wurz H (1989) Hormone levels in women after hysterectomy. Arch Gynecol Obstet 244,169-173.
17. Kupperman HS, Wetchler BB and Blatt MHG (1959) Contemporary therapy of the menopausal syndrome. J Am Med Assoc 171,1627-1636.
18. Lähteenmäki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J and Nilsson CG (1998) Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. Br Med J 316,1122-1126.
19. Menon RK, Okonofua FE, Agnew JE, Thomas M, Bell J, O'Brien, PMS and Dandona P (1987) Endocrine and metabolic effects of simple hysterectomy. Int J Gynaecol Obstet 25,459-463.
20. Muttukrishna S, Sharma S, Barlow DH, Ledger W, Groome N and Sathanandan M (2002) Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women. Hum Reprod 17,2535-2539.
21. Nilsson CG, Lähteenmäki PL and Luukkainen T (1984) Ovarian function in amennorheic and menstruating users of levonorgestrel-releasing intrauterine device. Fertil Steril 41,52-55.
22. Oldenhave A, Jaszmann LJB, Everaerd WThAM and Haspels AA (1993) Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 168,765-771.
23. Payne JF, Robboy SJ and Haney AF. (2002) Embolic microspheres within ovarian arterial vasculature after uterine artery embolisation. Obstet Gynecol 100,983-886.
24. Ranney B and Abu-Ghazaleh S (1977) The future function and fortune of ovarian tissue which is retained in vivo during hysterectomy. Am J Obstet Gynecol 128,626.
25. Riedel HH, Lehmann-Willenbrock E and Semm K (1986) Ovarian failure phenomena after hysterectomy. J Reprod Med 31,597-600.
26. Ronnerdag M and Odlind V (1999) Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 78,716-721.
27. Siddle N, Sarrel P and Whitehead M (1987) The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil. Steril 47,94-100.
28. Söderström-Anttila V, Tiitinen A and Hovatta O (1997) Levonorgestrel-releasing intrauterine device can be used in oocyte donors during ovarian stimulation. Hum Reprod 12,491-495.
29. Souza AZ, Fonseca AM, Izzo VM, Clauzet M and Salvatore A (1986) Ovarian histology and function after total abdominal hysterectomy. Obstet Gynecol 68,847-849.
30. Stadberg E, Mattsson LA and Milsom I (2000) Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand 79,286-292.
31. Stone SC, Dickey RP and Mickal A (1975) The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol 121,193-197.
32. Tulandi T, Sammour A, Valenti D, Child TJ, Seti L and Lin Tan S (2002) Ovarian reserve after uterine artery embolisation for leiomyomata. Fertil Steril 78,197-198.
33. Vuorento T, Mäenpää J and Huhtaniemi I (1992) Follow-up of ovarian endocrine function in premenopausal women after hysterectomy by daily measurements of salivary progesterone. Clin Endocrinol 36,505-510.
34. Vuorma S, Teperi J, Hurskainen R, Keskimaki I and Kujansuu E (1998) Hysterectomy trends in Finland 1987-1995 - a register based analysis. Acta Obstet Gynecol Scand 77,770-776.